Global Infectious Bursal Disease Vaccine Market Research Report 2025(Status and Outlook)
Report Overview
Infectious Bursal Disease Vaccine is used to prevent infectious bursal disease in chickens, which is one of the main infectious diseases in the chicken industry.
The global Infectious Bursal Disease Vaccine market size was estimated at USD 463.25 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 6.45% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Infectious Bursal Disease Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Infectious Bursal Disease Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Infectious Bursal Disease Vaccine market
Global Infectious Bursal Disease Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Zoetis
Merck
Elanco
Boehringer Ingelheim
Ceva
Qingdao Yibang Biological Engineering Co.Ltd.
Shandong Lvdu Biological Technology Co.Ltd.
Plyco Bioengineering Co.Ltd.
Ruipu Biopharmaceutical Co.Ltd.
Harbin Pharmaceutical Group Biological Vaccine Co.Ltd.
Market Segmentation (by Type)
Live
Inactivated
Market Segmentation (by Application)
Veterinary Pharmacy
Online Sale
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Infectious Bursal Disease Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Infectious Bursal Disease Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Infectious Bursal Disease Vaccine is used to prevent infectious bursal disease in chickens, which is one of the main infectious diseases in the chicken industry.
The global Infectious Bursal Disease Vaccine market size was estimated at USD 463.25 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 6.45% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Infectious Bursal Disease Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Infectious Bursal Disease Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Infectious Bursal Disease Vaccine market
Global Infectious Bursal Disease Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Zoetis
Merck
Elanco
Boehringer Ingelheim
Ceva
Qingdao Yibang Biological Engineering Co.Ltd.
Shandong Lvdu Biological Technology Co.Ltd.
Plyco Bioengineering Co.Ltd.
Ruipu Biopharmaceutical Co.Ltd.
Harbin Pharmaceutical Group Biological Vaccine Co.Ltd.
Market Segmentation (by Type)
Live
Inactivated
Market Segmentation (by Application)
Veterinary Pharmacy
Online Sale
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Infectious Bursal Disease Vaccine Market
- Overview of the regional outlook of the Infectious Bursal Disease Vaccine Market.
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Infectious Bursal Disease Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Infectious Bursal Disease Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Infectious Bursal Disease Vaccine
1.2 Key Market Segments
1.2.1 Infectious Bursal Disease Vaccine Segment by Type
1.2.2 Infectious Bursal Disease Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFECTIOUS BURSAL DISEASE VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Infectious Bursal Disease Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Infectious Bursal Disease Vaccine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFECTIOUS BURSAL DISEASE VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Infectious Bursal Disease Vaccine Product Life Cycle
3.3 Global Infectious Bursal Disease Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Infectious Bursal Disease Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Infectious Bursal Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Infectious Bursal Disease Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Infectious Bursal Disease Vaccine Market Competitive Situation and Trends
3.8.1 Infectious Bursal Disease Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Infectious Bursal Disease Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INFECTIOUS BURSAL DISEASE VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Infectious Bursal Disease Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFECTIOUS BURSAL DISEASE VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Infectious Bursal Disease Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Infectious Bursal Disease Vaccine Market
5.7 ESG Ratings of Leading Companies
6 INFECTIOUS BURSAL DISEASE VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Infectious Bursal Disease Vaccine Market Size Market Share by Type (2020-2025)
6.4 Global Infectious Bursal Disease Vaccine Price by Type (2020-2025)
7 INFECTIOUS BURSAL DISEASE VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Infectious Bursal Disease Vaccine Market Sales by Application (2020-2025)
7.3 Global Infectious Bursal Disease Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Infectious Bursal Disease Vaccine Sales Growth Rate by Application (2020-2025)
8 INFECTIOUS BURSAL DISEASE VACCINE MARKET SALES BY REGION
8.1 Global Infectious Bursal Disease Vaccine Sales by Region
8.1.1 Global Infectious Bursal Disease Vaccine Sales by Region
8.1.2 Global Infectious Bursal Disease Vaccine Sales Market Share by Region
8.2 Global Infectious Bursal Disease Vaccine Market Size by Region
8.2.1 Global Infectious Bursal Disease Vaccine Market Size by Region
8.2.2 Global Infectious Bursal Disease Vaccine Market Size Market Share by Region
8.3 North America
8.3.1 North America Infectious Bursal Disease Vaccine Sales by Country
8.3.2 North America Infectious Bursal Disease Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Infectious Bursal Disease Vaccine Sales by Country
8.4.2 Europe Infectious Bursal Disease Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Infectious Bursal Disease Vaccine Sales by Region
8.5.2 Asia Pacific Infectious Bursal Disease Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Infectious Bursal Disease Vaccine Sales by Country
8.6.2 South America Infectious Bursal Disease Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Infectious Bursal Disease Vaccine Sales by Region
8.7.2 Middle East and Africa Infectious Bursal Disease Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INFECTIOUS BURSAL DISEASE VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Infectious Bursal Disease Vaccine by Region(2020-2025)
9.2 Global Infectious Bursal Disease Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Infectious Bursal Disease Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Infectious Bursal Disease Vaccine Production
9.4.1 North America Infectious Bursal Disease Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Infectious Bursal Disease Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Infectious Bursal Disease Vaccine Production
9.5.1 Europe Infectious Bursal Disease Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Infectious Bursal Disease Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Infectious Bursal Disease Vaccine Production (2020-2025)
9.6.1 Japan Infectious Bursal Disease Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Infectious Bursal Disease Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Infectious Bursal Disease Vaccine Production (2020-2025)
9.7.1 China Infectious Bursal Disease Vaccine Production Growth Rate (2020-2025)
9.7.2 China Infectious Bursal Disease Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Zoetis
10.1.1 Zoetis Basic Information
10.1.2 Zoetis Infectious Bursal Disease Vaccine Product Overview
10.1.3 Zoetis Infectious Bursal Disease Vaccine Product Market Performance
10.1.4 Zoetis Business Overview
10.1.5 Zoetis SWOT Analysis
10.1.6 Zoetis Recent Developments
10.2 Merck
10.2.1 Merck Basic Information
10.2.2 Merck Infectious Bursal Disease Vaccine Product Overview
10.2.3 Merck Infectious Bursal Disease Vaccine Product Market Performance
10.2.4 Merck Business Overview
10.2.5 Merck SWOT Analysis
10.2.6 Merck Recent Developments
10.3 Elanco
10.3.1 Elanco Basic Information
10.3.2 Elanco Infectious Bursal Disease Vaccine Product Overview
10.3.3 Elanco Infectious Bursal Disease Vaccine Product Market Performance
10.3.4 Elanco Business Overview
10.3.5 Elanco SWOT Analysis
10.3.6 Elanco Recent Developments
10.4 Boehringer Ingelheim
10.4.1 Boehringer Ingelheim Basic Information
10.4.2 Boehringer Ingelheim Infectious Bursal Disease Vaccine Product Overview
10.4.3 Boehringer Ingelheim Infectious Bursal Disease Vaccine Product Market Performance
10.4.4 Boehringer Ingelheim Business Overview
10.4.5 Boehringer Ingelheim Recent Developments
10.5 Ceva
10.5.1 Ceva Basic Information
10.5.2 Ceva Infectious Bursal Disease Vaccine Product Overview
10.5.3 Ceva Infectious Bursal Disease Vaccine Product Market Performance
10.5.4 Ceva Business Overview
10.5.5 Ceva Recent Developments
10.6 Qingdao Yibang Biological Engineering Co.Ltd.
10.6.1 Qingdao Yibang Biological Engineering Co.Ltd. Basic Information
10.6.2 Qingdao Yibang Biological Engineering Co.Ltd. Infectious Bursal Disease Vaccine Product Overview
10.6.3 Qingdao Yibang Biological Engineering Co.Ltd. Infectious Bursal Disease Vaccine Product Market Performance
10.6.4 Qingdao Yibang Biological Engineering Co.Ltd. Business Overview
10.6.5 Qingdao Yibang Biological Engineering Co.Ltd. Recent Developments
10.7 Shandong Lvdu Biological Technology Co.Ltd.
10.7.1 Shandong Lvdu Biological Technology Co.Ltd. Basic Information
10.7.2 Shandong Lvdu Biological Technology Co.Ltd. Infectious Bursal Disease Vaccine Product Overview
10.7.3 Shandong Lvdu Biological Technology Co.Ltd. Infectious Bursal Disease Vaccine Product Market Performance
10.7.4 Shandong Lvdu Biological Technology Co.Ltd. Business Overview
10.7.5 Shandong Lvdu Biological Technology Co.Ltd. Recent Developments
10.8 Plyco Bioengineering Co.Ltd.
10.8.1 Plyco Bioengineering Co.Ltd. Basic Information
10.8.2 Plyco Bioengineering Co.Ltd. Infectious Bursal Disease Vaccine Product Overview
10.8.3 Plyco Bioengineering Co.Ltd. Infectious Bursal Disease Vaccine Product Market Performance
10.8.4 Plyco Bioengineering Co.Ltd. Business Overview
10.8.5 Plyco Bioengineering Co.Ltd. Recent Developments
10.9 Ruipu Biopharmaceutical Co.Ltd.
10.9.1 Ruipu Biopharmaceutical Co.Ltd. Basic Information
10.9.2 Ruipu Biopharmaceutical Co.Ltd. Infectious Bursal Disease Vaccine Product Overview
10.9.3 Ruipu Biopharmaceutical Co.Ltd. Infectious Bursal Disease Vaccine Product Market Performance
10.9.4 Ruipu Biopharmaceutical Co.Ltd. Business Overview
10.9.5 Ruipu Biopharmaceutical Co.Ltd. Recent Developments
10.10 Harbin Pharmaceutical Group Biological Vaccine Co.Ltd.
10.10.1 Harbin Pharmaceutical Group Biological Vaccine Co.Ltd. Basic Information
10.10.2 Harbin Pharmaceutical Group Biological Vaccine Co.Ltd. Infectious Bursal Disease Vaccine Product Overview
10.10.3 Harbin Pharmaceutical Group Biological Vaccine Co.Ltd. Infectious Bursal Disease Vaccine Product Market Performance
10.10.4 Harbin Pharmaceutical Group Biological Vaccine Co.Ltd. Business Overview
10.10.5 Harbin Pharmaceutical Group Biological Vaccine Co.Ltd. Recent Developments
11 INFECTIOUS BURSAL DISEASE VACCINE MARKET FORECAST BY REGION
11.1 Global Infectious Bursal Disease Vaccine Market Size Forecast
11.2 Global Infectious Bursal Disease Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Infectious Bursal Disease Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Infectious Bursal Disease Vaccine Market Size Forecast by Region
11.2.4 South America Infectious Bursal Disease Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Infectious Bursal Disease Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Infectious Bursal Disease Vaccine Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Infectious Bursal Disease Vaccine by Type (2026-2033)
12.1.2 Global Infectious Bursal Disease Vaccine Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Infectious Bursal Disease Vaccine by Type (2026-2033)
12.2 Global Infectious Bursal Disease Vaccine Market Forecast by Application (2026-2033)
12.2.1 Global Infectious Bursal Disease Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Infectious Bursal Disease Vaccine Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Infectious Bursal Disease Vaccine
1.2 Key Market Segments
1.2.1 Infectious Bursal Disease Vaccine Segment by Type
1.2.2 Infectious Bursal Disease Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFECTIOUS BURSAL DISEASE VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Infectious Bursal Disease Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Infectious Bursal Disease Vaccine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFECTIOUS BURSAL DISEASE VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Infectious Bursal Disease Vaccine Product Life Cycle
3.3 Global Infectious Bursal Disease Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Infectious Bursal Disease Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Infectious Bursal Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Infectious Bursal Disease Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Infectious Bursal Disease Vaccine Market Competitive Situation and Trends
3.8.1 Infectious Bursal Disease Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Infectious Bursal Disease Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INFECTIOUS BURSAL DISEASE VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Infectious Bursal Disease Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFECTIOUS BURSAL DISEASE VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Infectious Bursal Disease Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Infectious Bursal Disease Vaccine Market
5.7 ESG Ratings of Leading Companies
6 INFECTIOUS BURSAL DISEASE VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Infectious Bursal Disease Vaccine Market Size Market Share by Type (2020-2025)
6.4 Global Infectious Bursal Disease Vaccine Price by Type (2020-2025)
7 INFECTIOUS BURSAL DISEASE VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Infectious Bursal Disease Vaccine Market Sales by Application (2020-2025)
7.3 Global Infectious Bursal Disease Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Infectious Bursal Disease Vaccine Sales Growth Rate by Application (2020-2025)
8 INFECTIOUS BURSAL DISEASE VACCINE MARKET SALES BY REGION
8.1 Global Infectious Bursal Disease Vaccine Sales by Region
8.1.1 Global Infectious Bursal Disease Vaccine Sales by Region
8.1.2 Global Infectious Bursal Disease Vaccine Sales Market Share by Region
8.2 Global Infectious Bursal Disease Vaccine Market Size by Region
8.2.1 Global Infectious Bursal Disease Vaccine Market Size by Region
8.2.2 Global Infectious Bursal Disease Vaccine Market Size Market Share by Region
8.3 North America
8.3.1 North America Infectious Bursal Disease Vaccine Sales by Country
8.3.2 North America Infectious Bursal Disease Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Infectious Bursal Disease Vaccine Sales by Country
8.4.2 Europe Infectious Bursal Disease Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Infectious Bursal Disease Vaccine Sales by Region
8.5.2 Asia Pacific Infectious Bursal Disease Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Infectious Bursal Disease Vaccine Sales by Country
8.6.2 South America Infectious Bursal Disease Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Infectious Bursal Disease Vaccine Sales by Region
8.7.2 Middle East and Africa Infectious Bursal Disease Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INFECTIOUS BURSAL DISEASE VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Infectious Bursal Disease Vaccine by Region(2020-2025)
9.2 Global Infectious Bursal Disease Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Infectious Bursal Disease Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Infectious Bursal Disease Vaccine Production
9.4.1 North America Infectious Bursal Disease Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Infectious Bursal Disease Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Infectious Bursal Disease Vaccine Production
9.5.1 Europe Infectious Bursal Disease Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Infectious Bursal Disease Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Infectious Bursal Disease Vaccine Production (2020-2025)
9.6.1 Japan Infectious Bursal Disease Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Infectious Bursal Disease Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Infectious Bursal Disease Vaccine Production (2020-2025)
9.7.1 China Infectious Bursal Disease Vaccine Production Growth Rate (2020-2025)
9.7.2 China Infectious Bursal Disease Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Zoetis
10.1.1 Zoetis Basic Information
10.1.2 Zoetis Infectious Bursal Disease Vaccine Product Overview
10.1.3 Zoetis Infectious Bursal Disease Vaccine Product Market Performance
10.1.4 Zoetis Business Overview
10.1.5 Zoetis SWOT Analysis
10.1.6 Zoetis Recent Developments
10.2 Merck
10.2.1 Merck Basic Information
10.2.2 Merck Infectious Bursal Disease Vaccine Product Overview
10.2.3 Merck Infectious Bursal Disease Vaccine Product Market Performance
10.2.4 Merck Business Overview
10.2.5 Merck SWOT Analysis
10.2.6 Merck Recent Developments
10.3 Elanco
10.3.1 Elanco Basic Information
10.3.2 Elanco Infectious Bursal Disease Vaccine Product Overview
10.3.3 Elanco Infectious Bursal Disease Vaccine Product Market Performance
10.3.4 Elanco Business Overview
10.3.5 Elanco SWOT Analysis
10.3.6 Elanco Recent Developments
10.4 Boehringer Ingelheim
10.4.1 Boehringer Ingelheim Basic Information
10.4.2 Boehringer Ingelheim Infectious Bursal Disease Vaccine Product Overview
10.4.3 Boehringer Ingelheim Infectious Bursal Disease Vaccine Product Market Performance
10.4.4 Boehringer Ingelheim Business Overview
10.4.5 Boehringer Ingelheim Recent Developments
10.5 Ceva
10.5.1 Ceva Basic Information
10.5.2 Ceva Infectious Bursal Disease Vaccine Product Overview
10.5.3 Ceva Infectious Bursal Disease Vaccine Product Market Performance
10.5.4 Ceva Business Overview
10.5.5 Ceva Recent Developments
10.6 Qingdao Yibang Biological Engineering Co.Ltd.
10.6.1 Qingdao Yibang Biological Engineering Co.Ltd. Basic Information
10.6.2 Qingdao Yibang Biological Engineering Co.Ltd. Infectious Bursal Disease Vaccine Product Overview
10.6.3 Qingdao Yibang Biological Engineering Co.Ltd. Infectious Bursal Disease Vaccine Product Market Performance
10.6.4 Qingdao Yibang Biological Engineering Co.Ltd. Business Overview
10.6.5 Qingdao Yibang Biological Engineering Co.Ltd. Recent Developments
10.7 Shandong Lvdu Biological Technology Co.Ltd.
10.7.1 Shandong Lvdu Biological Technology Co.Ltd. Basic Information
10.7.2 Shandong Lvdu Biological Technology Co.Ltd. Infectious Bursal Disease Vaccine Product Overview
10.7.3 Shandong Lvdu Biological Technology Co.Ltd. Infectious Bursal Disease Vaccine Product Market Performance
10.7.4 Shandong Lvdu Biological Technology Co.Ltd. Business Overview
10.7.5 Shandong Lvdu Biological Technology Co.Ltd. Recent Developments
10.8 Plyco Bioengineering Co.Ltd.
10.8.1 Plyco Bioengineering Co.Ltd. Basic Information
10.8.2 Plyco Bioengineering Co.Ltd. Infectious Bursal Disease Vaccine Product Overview
10.8.3 Plyco Bioengineering Co.Ltd. Infectious Bursal Disease Vaccine Product Market Performance
10.8.4 Plyco Bioengineering Co.Ltd. Business Overview
10.8.5 Plyco Bioengineering Co.Ltd. Recent Developments
10.9 Ruipu Biopharmaceutical Co.Ltd.
10.9.1 Ruipu Biopharmaceutical Co.Ltd. Basic Information
10.9.2 Ruipu Biopharmaceutical Co.Ltd. Infectious Bursal Disease Vaccine Product Overview
10.9.3 Ruipu Biopharmaceutical Co.Ltd. Infectious Bursal Disease Vaccine Product Market Performance
10.9.4 Ruipu Biopharmaceutical Co.Ltd. Business Overview
10.9.5 Ruipu Biopharmaceutical Co.Ltd. Recent Developments
10.10 Harbin Pharmaceutical Group Biological Vaccine Co.Ltd.
10.10.1 Harbin Pharmaceutical Group Biological Vaccine Co.Ltd. Basic Information
10.10.2 Harbin Pharmaceutical Group Biological Vaccine Co.Ltd. Infectious Bursal Disease Vaccine Product Overview
10.10.3 Harbin Pharmaceutical Group Biological Vaccine Co.Ltd. Infectious Bursal Disease Vaccine Product Market Performance
10.10.4 Harbin Pharmaceutical Group Biological Vaccine Co.Ltd. Business Overview
10.10.5 Harbin Pharmaceutical Group Biological Vaccine Co.Ltd. Recent Developments
11 INFECTIOUS BURSAL DISEASE VACCINE MARKET FORECAST BY REGION
11.1 Global Infectious Bursal Disease Vaccine Market Size Forecast
11.2 Global Infectious Bursal Disease Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Infectious Bursal Disease Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Infectious Bursal Disease Vaccine Market Size Forecast by Region
11.2.4 South America Infectious Bursal Disease Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Infectious Bursal Disease Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Infectious Bursal Disease Vaccine Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Infectious Bursal Disease Vaccine by Type (2026-2033)
12.1.2 Global Infectious Bursal Disease Vaccine Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Infectious Bursal Disease Vaccine by Type (2026-2033)
12.2 Global Infectious Bursal Disease Vaccine Market Forecast by Application (2026-2033)
12.2.1 Global Infectious Bursal Disease Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Infectious Bursal Disease Vaccine Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Infectious Bursal Disease Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Infectious Bursal Disease Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Infectious Bursal Disease Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Infectious Bursal Disease Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Infectious Bursal Disease Vaccine Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Bursal Disease Vaccine as of 2024)
Table 10. Global Market Infectious Bursal Disease Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Infectious Bursal Disease Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Infectious Bursal Disease Vaccine Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Infectious Bursal Disease Vaccine Sales by Type (K MT)
Table 26. Global Infectious Bursal Disease Vaccine Market Size by Type (M USD)
Table 27. Global Infectious Bursal Disease Vaccine Sales (K MT) by Type (2020-2025)
Table 28. Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2020-2025)
Table 29. Global Infectious Bursal Disease Vaccine Market Size (M USD) by Type (2020-2025)
Table 30. Global Infectious Bursal Disease Vaccine Market Size Share by Type (2020-2025)
Table 31. Global Infectious Bursal Disease Vaccine Price (USD/KG) by Type (2020-2025)
Table 32. Global Infectious Bursal Disease Vaccine Sales (K MT) by Application
Table 33. Global Infectious Bursal Disease Vaccine Market Size by Application
Table 34. Global Infectious Bursal Disease Vaccine Sales by Application (2020-2025) & (K MT)
Table 35. Global Infectious Bursal Disease Vaccine Sales Market Share by Application (2020-2025)
Table 36. Global Infectious Bursal Disease Vaccine Market Size by Application (2020-2025) & (M USD)
Table 37. Global Infectious Bursal Disease Vaccine Market Share by Application (2020-2025)
Table 38. Global Infectious Bursal Disease Vaccine Sales Growth Rate by Application (2020-2025)
Table 39. Global Infectious Bursal Disease Vaccine Sales by Region (2020-2025) & (K MT)
Table 40. Global Infectious Bursal Disease Vaccine Sales Market Share by Region (2020-2025)
Table 41. Global Infectious Bursal Disease Vaccine Market Size by Region (2020-2025) & (M USD)
Table 42. Global Infectious Bursal Disease Vaccine Market Size Market Share by Region (2020-2025)
Table 43. North America Infectious Bursal Disease Vaccine Sales by Country (2020-2025) & (K MT)
Table 44. North America Infectious Bursal Disease Vaccine Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Infectious Bursal Disease Vaccine Sales by Country (2020-2025) & (K MT)
Table 46. Europe Infectious Bursal Disease Vaccine Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Infectious Bursal Disease Vaccine Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Infectious Bursal Disease Vaccine Market Size by Region (2020-2025) & (M USD)
Table 49. South America Infectious Bursal Disease Vaccine Sales by Country (2020-2025) & (K MT)
Table 50. South America Infectious Bursal Disease Vaccine Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Infectious Bursal Disease Vaccine Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Infectious Bursal Disease Vaccine Market Size by Region (2020-2025) & (M USD)
Table 53. Global Infectious Bursal Disease Vaccine Production (K MT) by Region(2020-2025)
Table 54. Global Infectious Bursal Disease Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Infectious Bursal Disease Vaccine Revenue Market Share by Region (2020-2025)
Table 56. Global Infectious Bursal Disease Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Infectious Bursal Disease Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Infectious Bursal Disease Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Infectious Bursal Disease Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Infectious Bursal Disease Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Zoetis Basic Information
Table 62. Zoetis Infectious Bursal Disease Vaccine Product Overview
Table 63. Zoetis Infectious Bursal Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Zoetis Business Overview
Table 65. Zoetis SWOT Analysis
Table 66. Zoetis Recent Developments
Table 67. Merck Basic Information
Table 68. Merck Infectious Bursal Disease Vaccine Product Overview
Table 69. Merck Infectious Bursal Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Merck Business Overview
Table 71. Merck SWOT Analysis
Table 72. Merck Recent Developments
Table 73. Elanco Basic Information
Table 74. Elanco Infectious Bursal Disease Vaccine Product Overview
Table 75. Elanco Infectious Bursal Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Elanco Business Overview
Table 77. Elanco SWOT Analysis
Table 78. Elanco Recent Developments
Table 79. Boehringer Ingelheim Basic Information
Table 80. Boehringer Ingelheim Infectious Bursal Disease Vaccine Product Overview
Table 81. Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Boehringer Ingelheim Business Overview
Table 83. Boehringer Ingelheim Recent Developments
Table 84. Ceva Basic Information
Table 85. Ceva Infectious Bursal Disease Vaccine Product Overview
Table 86. Ceva Infectious Bursal Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Ceva Business Overview
Table 88. Ceva Recent Developments
Table 89. Qingdao Yibang Biological Engineering Co.Ltd. Basic Information
Table 90. Qingdao Yibang Biological Engineering Co.Ltd. Infectious Bursal Disease Vaccine Product Overview
Table 91. Qingdao Yibang Biological Engineering Co.Ltd. Infectious Bursal Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Qingdao Yibang Biological Engineering Co.Ltd. Business Overview
Table 93. Qingdao Yibang Biological Engineering Co.Ltd. Recent Developments
Table 94. Shandong Lvdu Biological Technology Co.Ltd. Basic Information
Table 95. Shandong Lvdu Biological Technology Co.Ltd. Infectious Bursal Disease Vaccine Product Overview
Table 96. Shandong Lvdu Biological Technology Co.Ltd. Infectious Bursal Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Shandong Lvdu Biological Technology Co.Ltd. Business Overview
Table 98. Shandong Lvdu Biological Technology Co.Ltd. Recent Developments
Table 99. Plyco Bioengineering Co.Ltd. Basic Information
Table 100. Plyco Bioengineering Co.Ltd. Infectious Bursal Disease Vaccine Product Overview
Table 101. Plyco Bioengineering Co.Ltd. Infectious Bursal Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Plyco Bioengineering Co.Ltd. Business Overview
Table 103. Plyco Bioengineering Co.Ltd. Recent Developments
Table 104. Ruipu Biopharmaceutical Co.Ltd. Basic Information
Table 105. Ruipu Biopharmaceutical Co.Ltd. Infectious Bursal Disease Vaccine Product Overview
Table 106. Ruipu Biopharmaceutical Co.Ltd. Infectious Bursal Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. Ruipu Biopharmaceutical Co.Ltd. Business Overview
Table 108. Ruipu Biopharmaceutical Co.Ltd. Recent Developments
Table 109. Harbin Pharmaceutical Group Biological Vaccine Co.Ltd. Basic Information
Table 110. Harbin Pharmaceutical Group Biological Vaccine Co.Ltd. Infectious Bursal Disease Vaccine Product Overview
Table 111. Harbin Pharmaceutical Group Biological Vaccine Co.Ltd. Infectious Bursal Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Harbin Pharmaceutical Group Biological Vaccine Co.Ltd. Business Overview
Table 113. Harbin Pharmaceutical Group Biological Vaccine Co.Ltd. Recent Developments
Table 114. Global Infectious Bursal Disease Vaccine Sales Forecast by Region (2026-2033) & (K MT)
Table 115. Global Infectious Bursal Disease Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 116. North America Infectious Bursal Disease Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 117. North America Infectious Bursal Disease Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 118. Europe Infectious Bursal Disease Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 119. Europe Infectious Bursal Disease Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 120. Asia Pacific Infectious Bursal Disease Vaccine Sales Forecast by Region (2026-2033) & (K MT)
Table 121. Asia Pacific Infectious Bursal Disease Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 122. South America Infectious Bursal Disease Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 123. South America Infectious Bursal Disease Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 124. Middle East and Africa Infectious Bursal Disease Vaccine Sales Forecast by Country (2026-2033) & (Units)
Table 125. Middle East and Africa Infectious Bursal Disease Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 126. Global Infectious Bursal Disease Vaccine Sales Forecast by Type (2026-2033) & (K MT)
Table 127. Global Infectious Bursal Disease Vaccine Market Size Forecast by Type (2026-2033) & (M USD)
Table 128. Global Infectious Bursal Disease Vaccine Price Forecast by Type (2026-2033) & (USD/KG)
Table 129. Global Infectious Bursal Disease Vaccine Sales (K MT) Forecast by Application (2026-2033)
Table 130. Global Infectious Bursal Disease Vaccine Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Infectious Bursal Disease Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Infectious Bursal Disease Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Infectious Bursal Disease Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Infectious Bursal Disease Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Infectious Bursal Disease Vaccine Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Bursal Disease Vaccine as of 2024)
Table 10. Global Market Infectious Bursal Disease Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Infectious Bursal Disease Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Infectious Bursal Disease Vaccine Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Infectious Bursal Disease Vaccine Sales by Type (K MT)
Table 26. Global Infectious Bursal Disease Vaccine Market Size by Type (M USD)
Table 27. Global Infectious Bursal Disease Vaccine Sales (K MT) by Type (2020-2025)
Table 28. Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2020-2025)
Table 29. Global Infectious Bursal Disease Vaccine Market Size (M USD) by Type (2020-2025)
Table 30. Global Infectious Bursal Disease Vaccine Market Size Share by Type (2020-2025)
Table 31. Global Infectious Bursal Disease Vaccine Price (USD/KG) by Type (2020-2025)
Table 32. Global Infectious Bursal Disease Vaccine Sales (K MT) by Application
Table 33. Global Infectious Bursal Disease Vaccine Market Size by Application
Table 34. Global Infectious Bursal Disease Vaccine Sales by Application (2020-2025) & (K MT)
Table 35. Global Infectious Bursal Disease Vaccine Sales Market Share by Application (2020-2025)
Table 36. Global Infectious Bursal Disease Vaccine Market Size by Application (2020-2025) & (M USD)
Table 37. Global Infectious Bursal Disease Vaccine Market Share by Application (2020-2025)
Table 38. Global Infectious Bursal Disease Vaccine Sales Growth Rate by Application (2020-2025)
Table 39. Global Infectious Bursal Disease Vaccine Sales by Region (2020-2025) & (K MT)
Table 40. Global Infectious Bursal Disease Vaccine Sales Market Share by Region (2020-2025)
Table 41. Global Infectious Bursal Disease Vaccine Market Size by Region (2020-2025) & (M USD)
Table 42. Global Infectious Bursal Disease Vaccine Market Size Market Share by Region (2020-2025)
Table 43. North America Infectious Bursal Disease Vaccine Sales by Country (2020-2025) & (K MT)
Table 44. North America Infectious Bursal Disease Vaccine Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Infectious Bursal Disease Vaccine Sales by Country (2020-2025) & (K MT)
Table 46. Europe Infectious Bursal Disease Vaccine Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Infectious Bursal Disease Vaccine Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Infectious Bursal Disease Vaccine Market Size by Region (2020-2025) & (M USD)
Table 49. South America Infectious Bursal Disease Vaccine Sales by Country (2020-2025) & (K MT)
Table 50. South America Infectious Bursal Disease Vaccine Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Infectious Bursal Disease Vaccine Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Infectious Bursal Disease Vaccine Market Size by Region (2020-2025) & (M USD)
Table 53. Global Infectious Bursal Disease Vaccine Production (K MT) by Region(2020-2025)
Table 54. Global Infectious Bursal Disease Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Infectious Bursal Disease Vaccine Revenue Market Share by Region (2020-2025)
Table 56. Global Infectious Bursal Disease Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Infectious Bursal Disease Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Infectious Bursal Disease Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Infectious Bursal Disease Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Infectious Bursal Disease Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Zoetis Basic Information
Table 62. Zoetis Infectious Bursal Disease Vaccine Product Overview
Table 63. Zoetis Infectious Bursal Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Zoetis Business Overview
Table 65. Zoetis SWOT Analysis
Table 66. Zoetis Recent Developments
Table 67. Merck Basic Information
Table 68. Merck Infectious Bursal Disease Vaccine Product Overview
Table 69. Merck Infectious Bursal Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Merck Business Overview
Table 71. Merck SWOT Analysis
Table 72. Merck Recent Developments
Table 73. Elanco Basic Information
Table 74. Elanco Infectious Bursal Disease Vaccine Product Overview
Table 75. Elanco Infectious Bursal Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Elanco Business Overview
Table 77. Elanco SWOT Analysis
Table 78. Elanco Recent Developments
Table 79. Boehringer Ingelheim Basic Information
Table 80. Boehringer Ingelheim Infectious Bursal Disease Vaccine Product Overview
Table 81. Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Boehringer Ingelheim Business Overview
Table 83. Boehringer Ingelheim Recent Developments
Table 84. Ceva Basic Information
Table 85. Ceva Infectious Bursal Disease Vaccine Product Overview
Table 86. Ceva Infectious Bursal Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Ceva Business Overview
Table 88. Ceva Recent Developments
Table 89. Qingdao Yibang Biological Engineering Co.Ltd. Basic Information
Table 90. Qingdao Yibang Biological Engineering Co.Ltd. Infectious Bursal Disease Vaccine Product Overview
Table 91. Qingdao Yibang Biological Engineering Co.Ltd. Infectious Bursal Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Qingdao Yibang Biological Engineering Co.Ltd. Business Overview
Table 93. Qingdao Yibang Biological Engineering Co.Ltd. Recent Developments
Table 94. Shandong Lvdu Biological Technology Co.Ltd. Basic Information
Table 95. Shandong Lvdu Biological Technology Co.Ltd. Infectious Bursal Disease Vaccine Product Overview
Table 96. Shandong Lvdu Biological Technology Co.Ltd. Infectious Bursal Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Shandong Lvdu Biological Technology Co.Ltd. Business Overview
Table 98. Shandong Lvdu Biological Technology Co.Ltd. Recent Developments
Table 99. Plyco Bioengineering Co.Ltd. Basic Information
Table 100. Plyco Bioengineering Co.Ltd. Infectious Bursal Disease Vaccine Product Overview
Table 101. Plyco Bioengineering Co.Ltd. Infectious Bursal Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Plyco Bioengineering Co.Ltd. Business Overview
Table 103. Plyco Bioengineering Co.Ltd. Recent Developments
Table 104. Ruipu Biopharmaceutical Co.Ltd. Basic Information
Table 105. Ruipu Biopharmaceutical Co.Ltd. Infectious Bursal Disease Vaccine Product Overview
Table 106. Ruipu Biopharmaceutical Co.Ltd. Infectious Bursal Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. Ruipu Biopharmaceutical Co.Ltd. Business Overview
Table 108. Ruipu Biopharmaceutical Co.Ltd. Recent Developments
Table 109. Harbin Pharmaceutical Group Biological Vaccine Co.Ltd. Basic Information
Table 110. Harbin Pharmaceutical Group Biological Vaccine Co.Ltd. Infectious Bursal Disease Vaccine Product Overview
Table 111. Harbin Pharmaceutical Group Biological Vaccine Co.Ltd. Infectious Bursal Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Harbin Pharmaceutical Group Biological Vaccine Co.Ltd. Business Overview
Table 113. Harbin Pharmaceutical Group Biological Vaccine Co.Ltd. Recent Developments
Table 114. Global Infectious Bursal Disease Vaccine Sales Forecast by Region (2026-2033) & (K MT)
Table 115. Global Infectious Bursal Disease Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 116. North America Infectious Bursal Disease Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 117. North America Infectious Bursal Disease Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 118. Europe Infectious Bursal Disease Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 119. Europe Infectious Bursal Disease Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 120. Asia Pacific Infectious Bursal Disease Vaccine Sales Forecast by Region (2026-2033) & (K MT)
Table 121. Asia Pacific Infectious Bursal Disease Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 122. South America Infectious Bursal Disease Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 123. South America Infectious Bursal Disease Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 124. Middle East and Africa Infectious Bursal Disease Vaccine Sales Forecast by Country (2026-2033) & (Units)
Table 125. Middle East and Africa Infectious Bursal Disease Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 126. Global Infectious Bursal Disease Vaccine Sales Forecast by Type (2026-2033) & (K MT)
Table 127. Global Infectious Bursal Disease Vaccine Market Size Forecast by Type (2026-2033) & (M USD)
Table 128. Global Infectious Bursal Disease Vaccine Price Forecast by Type (2026-2033) & (USD/KG)
Table 129. Global Infectious Bursal Disease Vaccine Sales (K MT) Forecast by Application (2026-2033)
Table 130. Global Infectious Bursal Disease Vaccine Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Infectious Bursal Disease Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Infectious Bursal Disease Vaccine Market Size (M USD), 2024-2033
Figure 5. Global Infectious Bursal Disease Vaccine Market Size (M USD) (2020-2033)
Figure 6. Global Infectious Bursal Disease Vaccine Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Infectious Bursal Disease Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Infectious Bursal Disease Vaccine Product Life Cycle
Figure 13. Infectious Bursal Disease Vaccine Sales Share by Manufacturers in 2024
Figure 14. Global Infectious Bursal Disease Vaccine Revenue Share by Manufacturers in 2024
Figure 15. Infectious Bursal Disease Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Infectious Bursal Disease Vaccine Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Infectious Bursal Disease Vaccine Revenue in 2024
Figure 18. Industry Chain Map of Infectious Bursal Disease Vaccine
Figure 19. Global Infectious Bursal Disease Vaccine Market PEST Analysis
Figure 20. Global Infectious Bursal Disease Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Infectious Bursal Disease Vaccine Market Share by Type
Figure 27. Sales Market Share of Infectious Bursal Disease Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Infectious Bursal Disease Vaccine by Type in 2024
Figure 29. Market Size Share of Infectious Bursal Disease Vaccine by Type (2020-2025)
Figure 30. Market Size Share of Infectious Bursal Disease Vaccine by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Infectious Bursal Disease Vaccine Market Share by Application
Figure 33. Global Infectious Bursal Disease Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Infectious Bursal Disease Vaccine Sales Market Share by Application in 2024
Figure 35. Global Infectious Bursal Disease Vaccine Market Share by Application (2020-2025)
Figure 36. Global Infectious Bursal Disease Vaccine Market Share by Application in 2024
Figure 37. Global Infectious Bursal Disease Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Infectious Bursal Disease Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Infectious Bursal Disease Vaccine Market Size Market Share by Region (2020-2025)
Figure 40. North America Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Infectious Bursal Disease Vaccine Sales Market Share by Country in 2024
Figure 43. North America Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Infectious Bursal Disease Vaccine Market Size Market Share by Country in 2024
Figure 45. U.S. Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Infectious Bursal Disease Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Infectious Bursal Disease Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Infectious Bursal Disease Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Infectious Bursal Disease Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Infectious Bursal Disease Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Infectious Bursal Disease Vaccine Market Size Market Share by Country in 2024
Figure 55. Germany Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Infectious Bursal Disease Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Infectious Bursal Disease Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Infectious Bursal Disease Vaccine Market Size Market Share by Region in 2024
Figure 68. China Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Infectious Bursal Disease Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Infectious Bursal Disease Vaccine Sales Market Share by Country in 2024
Figure 80. South America Infectious Bursal Disease Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Infectious Bursal Disease Vaccine Market Size Market Share by Country in 2024
Figure 82. Brazil Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Infectious Bursal Disease Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Infectious Bursal Disease Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Infectious Bursal Disease Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Infectious Bursal Disease Vaccine Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Infectious Bursal Disease Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Infectious Bursal Disease Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Infectious Bursal Disease Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Infectious Bursal Disease Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Infectious Bursal Disease Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Infectious Bursal Disease Vaccine Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Infectious Bursal Disease Vaccine Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Infectious Bursal Disease Vaccine Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Infectious Bursal Disease Vaccine Market Share Forecast by Type (2026-2033)
Figure 111. Global Infectious Bursal Disease Vaccine Sales Forecast by Application (2026-2033)
Figure 112. Global Infectious Bursal Disease Vaccine Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Infectious Bursal Disease Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Infectious Bursal Disease Vaccine Market Size (M USD), 2024-2033
Figure 5. Global Infectious Bursal Disease Vaccine Market Size (M USD) (2020-2033)
Figure 6. Global Infectious Bursal Disease Vaccine Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Infectious Bursal Disease Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Infectious Bursal Disease Vaccine Product Life Cycle
Figure 13. Infectious Bursal Disease Vaccine Sales Share by Manufacturers in 2024
Figure 14. Global Infectious Bursal Disease Vaccine Revenue Share by Manufacturers in 2024
Figure 15. Infectious Bursal Disease Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Infectious Bursal Disease Vaccine Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Infectious Bursal Disease Vaccine Revenue in 2024
Figure 18. Industry Chain Map of Infectious Bursal Disease Vaccine
Figure 19. Global Infectious Bursal Disease Vaccine Market PEST Analysis
Figure 20. Global Infectious Bursal Disease Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Infectious Bursal Disease Vaccine Market Share by Type
Figure 27. Sales Market Share of Infectious Bursal Disease Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Infectious Bursal Disease Vaccine by Type in 2024
Figure 29. Market Size Share of Infectious Bursal Disease Vaccine by Type (2020-2025)
Figure 30. Market Size Share of Infectious Bursal Disease Vaccine by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Infectious Bursal Disease Vaccine Market Share by Application
Figure 33. Global Infectious Bursal Disease Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Infectious Bursal Disease Vaccine Sales Market Share by Application in 2024
Figure 35. Global Infectious Bursal Disease Vaccine Market Share by Application (2020-2025)
Figure 36. Global Infectious Bursal Disease Vaccine Market Share by Application in 2024
Figure 37. Global Infectious Bursal Disease Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Infectious Bursal Disease Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Infectious Bursal Disease Vaccine Market Size Market Share by Region (2020-2025)
Figure 40. North America Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Infectious Bursal Disease Vaccine Sales Market Share by Country in 2024
Figure 43. North America Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Infectious Bursal Disease Vaccine Market Size Market Share by Country in 2024
Figure 45. U.S. Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Infectious Bursal Disease Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Infectious Bursal Disease Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Infectious Bursal Disease Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Infectious Bursal Disease Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Infectious Bursal Disease Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Infectious Bursal Disease Vaccine Market Size Market Share by Country in 2024
Figure 55. Germany Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Infectious Bursal Disease Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Infectious Bursal Disease Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Infectious Bursal Disease Vaccine Market Size Market Share by Region in 2024
Figure 68. China Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Infectious Bursal Disease Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Infectious Bursal Disease Vaccine Sales Market Share by Country in 2024
Figure 80. South America Infectious Bursal Disease Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Infectious Bursal Disease Vaccine Market Size Market Share by Country in 2024
Figure 82. Brazil Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Infectious Bursal Disease Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Infectious Bursal Disease Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Infectious Bursal Disease Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Infectious Bursal Disease Vaccine Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Infectious Bursal Disease Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Infectious Bursal Disease Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Infectious Bursal Disease Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Infectious Bursal Disease Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Infectious Bursal Disease Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Infectious Bursal Disease Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Infectious Bursal Disease Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Infectious Bursal Disease Vaccine Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Infectious Bursal Disease Vaccine Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Infectious Bursal Disease Vaccine Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Infectious Bursal Disease Vaccine Market Share Forecast by Type (2026-2033)
Figure 111. Global Infectious Bursal Disease Vaccine Sales Forecast by Application (2026-2033)
Figure 112. Global Infectious Bursal Disease Vaccine Market Share Forecast by Application (2026-2033)
